CROX vs PFE · rev $4.10B vs P/E 20, rev $62.58B
Crocs Inc (CROX) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Crocs Inc (CROX) is a footwear & accessories company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported CROX revenue for 2024-12-31 was $4.10B. Net income was $950.1M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. CROX currently screens at market cap $5.93B.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
CROX currently screens at market cap $5.93B. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the CROX and PFE stock pages for the full models.
Not investment advice.